João Pedro Ignotti de Almeida

João Pedro Ignotti de Almeida

Auto-generated profile, based on publicly available information

João Pedro Ignotti de Almeida

Universidade Federal do Paraná Curitiba PR Brasil Universidade Federal do Paraná, Curitiba, PR, Brasil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ISIsabela Busto Silva
Isabela Busto Silva
GCGisah Amaral de Carvalho
Gisah Amaral de Carvalho
FMFabiola Miasaki
Fabiola Miasaki
JAJoão Pedro Ignotti de Almeida
João Pedro Ignotti de Almeida
MSMatheus Pessini Sousa
Matheus Pessini Sousa
CJCléo Otaviano Mesa Júnior
Cléo Otaviano Mesa Júnior
Objective: To evaluate and describe the changes in the therapeutic approach to Graves’ disease at a tertiary hospital center over a 20-year period, with an emphasis on the frequency of prescription and the timing of radioactive iodine indication. Subjects and methods: We conducted a retrospective analysis of data from medical records of patients recently diagnosed with Graves’ disease (GD) and followed up at a single institution during two consecutive periods: Group A diagnosed between 2002 and 2010, and Group [...] ABSTRACT Objective: To evaluate and describe the changes in the therapeutic approach to Graves’ disease at a tertiary hospital center over a 20-year period, with an emphasis on the frequency of prescription and the timing of radioactive iodine indication. Subjects and methods: We conducted a retrospective analysis of data from medical records of patients recently diagnosed with Graves’ disease (GD) and followed up at a single institution during two consecutive periods: Group A diagnosed between 2002 and 2010, and Group

1 January 2026 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
ISIsabela Busto Silva
Isabela Busto Silva
GCGisah Amaral de Carvalho
Gisah Amaral de Carvalho
FMFabiola Miasaki
Fabiola Miasaki
JAJoão Pedro Ignotti de Almeida
João Pedro Ignotti de Almeida
MSMatheus Pessini Sousa
Matheus Pessini Sousa
CJCléo Otaviano Mesa Júnior
Cléo Otaviano Mesa Júnior
Objective: To evaluate remission and relapse rates in patients with Graves’ disease treated with methimazole and to identify clinical and laboratory predictors of these outcomes. Subjects and methods: We conducted a retrospective cohort study of 425 adult patients newly diagnosed with Graves’ disease at a single tertiary center between 2002 and 2022. All patients received methimazole for at least 12 months. Remission was defined as drug-free biochemical euthyroidism for 12 months or longer after therapy withdrawal. Univariate and multivariate [...] ABSTRACT Objective: To evaluate remission and relapse rates in patients with Graves’ disease treated with methimazole and to identify clinical and laboratory predictors of these outcomes. Subjects and methods: We conducted a retrospective cohort study of 425 adult patients newly diagnosed with Graves’ disease at a single tertiary center between 2002 and 2022. All patients received methimazole for at least 12 months. Remission was defined as drug-free biochemical euthyroidism for 12 months or longer after therapy withdrawal. Univariate and multivariate